Portal de Periódicos da CAPES

Extracorporeal carbon dioxide removal for lowering the risk of mechanical ventilation: research questions and clinical potential for the future

2018; Elsevier BV; Volume: 6; Issue: 11 Linguagem: Inglês

10.1016/s2213-2600(18)30326-6

2213-2619

Andrew Boyle, Michael C. Sklar, James J. McNamee, Daniel Brodie, Arthur S. Slutsky, Laurent Brochard, Daniel F. McAuley, Darryl Abrams, Alain Combes, Eddy Fan, John F. Fraser, Carol Hodgson, Nicoló Patroniti, Antonio Artigas, Rob Mac Sweeney, J Manacebo, Thomas Mueller, Tài Pham, Marco Ranieri, Matthieu Schmidt, Kiran Shekar,

Cardiac Arrest and Resuscitation

As a result of technical improvements, extracorporeal carbon dioxide removal (ECCO2R) now has the potential to play an important role in the management of adults with acute respiratory failure. There is growing interest in the use of ECCO2R for the management of both hypoxaemic and hypercapnic respiratory failure. However, evidence to support its use is scarce and several questions remain about the best way to implement this therapy, which can be associated with serious side-effects. This Review reflects the consensus opinion of an international group of clinician scientists with expertise in managing acute respiratory failure and in using ECCO2R therapies in this setting. We concisely review clinically relevant aspects of ECCO2R, and provide a series of recommendations for clinical practice and future research, covering topics that include the practicalities of ECCO2R delivery, indications for use, and service delivery.